Vanguard Group Inc Essa Pharma Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.15 - $7.94 $35,217 - $88,769	-11,180 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$6.18 - $14.44 $370,287 - $865,201	-59,917 Reduced 84.28%	11,180 $70,000
Q4 2021 Feb 14, 2022	SELL	$7.8 - $14.38 $564,080 - $1.04 Million	-72,318 Reduced 50.43%	71,097 $1.01 Million
Q3 2021 Nov 12, 2021	BUY	$7.76 - $29.37 $527,035 - $1.99 Million	67,917 Added 89.96%	143,415 $1.15 Million
Q2 2021 Aug 13, 2021	BUY	$24.17 - $34.28 $1.82 Million - $2.59 Million	75,498 New	75,498 $2.16 Million

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $72.3M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.